If the results are confirmed in humans, the implications for personalized therapies for other cancers could mean fewer radiation treatments, or perhaps, ideally, one single high-dose treatment.
A multidisciplinary team at UT Southwestern Medical Center has found that measuring the oxygenation of tumors can be a valuable tool in guiding radiation therapy, opening the door for personalized therapies that keep tumors in check with oxygen enhancement.
In research examining tissue oxygenation levels and predicting radiation response, UT Southwestern scientists led by Dr. Ralph Mason reported in the June 27 online issue of Magnetic Resonance in Medicine that countering hypoxic and aggressive tumors with an “oxygen challenge” – inhaling oxygen while monitoring tumor response – coincides with a greater delay in tumor growth in an irradiated animal model.
Over the past several years, the research of Dr. Mason, professor of radiology and the paper’s senior author, and his colleagues has been building on findings that show lack of oxygen actually stimulates the growth of new blood vessels in tumors and leads to metastasis and genetic instability in cancer. The theory follows that breathing oxygen or enriching the oxygen content of hypoxic (low in oxygen) cancer tissues improves therapy.
In the current study, supported by the National Cancer Institute, smaller tumors based on magnetic resonance imaging were found to be significantly better oxygenated than larger ones. This confirmed previous investigations that show a range of hypoxic environments depending on the size of the tumor.
“The next step is clinical trials to assess tumor response to radiation therapy,” said Dr. Mason, director of the cancer imaging program at the medical center. “Tumors determined to be hypoxic can be evaluated and made responsive through mild and easy-to-administer interventions, such as breathing more oxygen or taking a vasoactive drug. Monitoring the response to oxygen breathing tells us which tumors will benefit.”
If the results are confirmed in humans, the implications for personalized therapies for other cancers could mean fewer radiation treatments, or perhaps, ideally, one single high-dose treatment. Lung cancer, for instance, is a form of the disease whose tumors are poorly oxygenated despite being located in the principle organ charged with oxygenating the blood.
“The ability to stratify tumors based on hypoxia offers new opportunities to tailor therapy to tumor characteristics, potentially enhancing success through personalized medicine,” Dr. Mason said.
Together with Dr. Robert Timmerman, professor of radiation oncology at the Harold C. Simmons Cancer Center, and Dr. Ivan Pedrosa, professor of radiology and the Advanced Imaging Research Center, Dr. Mason is starting clinical trials to assess the effectiveness of oxygenation during treatment with stereotactic body radiation in humans – work that is supported by the Cancer Prevention and Research Institute of Texas (CPRIT) through one of its Multi-Investigator Research Awards.
With CPRIT support, Dr. Mason’s team has worked to understand how low oxygen concentration can cause radiation resistance in tumors. In some cases, the simple addition of oxygen to stereotactic body radiation greatly improves response. The key is to identify those patients who will benefit.
The Latest Bing News on:
Personalized cancer therapies
- Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testingon April 19, 2021 at 4:08 am
Amgen (NASDAQ: AMGN) today announced the launch of Biomarker Assist™, a program to help more patients with metastatic (stage IV) non-small cell lung cancer (NSCLC) gain access to biomarker testing.
- Genetic Markers Discovered that Open Door to Potential New Lung Cancer Therapieson April 16, 2021 at 5:00 am
Mutations in KMT2C and KMT2D genes make non-small cell lung cancer more sensitive to Poly (ADP-ribose) polymerase (PARP) inhibitors, which are already approved for certain types of cancer.
- New genetic markers may lead to personalized treatments for lung canceron April 14, 2021 at 9:45 pm
Investigators at Wake Forest School of Medicine, part of Wake Forest Baptist Health, have identified a set of new genetic markers that could potentially lead to new personalized treatments for lung ...
- UCSD Health: How Cancer Care is Personalizedon April 13, 2021 at 3:37 pm
UC San Diego Health is the only Comprehensive Cancer Center in San Diego and one of only fifty-one in the nation. This prestigious recognition is bestowed by the National Cancer Institute (NCI), the ...
- Multi-Omics Approach to Personalized Therapy Shows Feasibility in Metastatic Breast Canceron April 13, 2021 at 8:23 am
A multi-omics approach to personalized therapy that incorporates information about actionable oncogenic drivers with critical biological data has demonstrated feasibility in patients metastatic breast ...
- Personalized cancer vaccine deemed safe, shows potential benefit against canceron April 13, 2021 at 5:58 am
A personalized cancer vaccine raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to ...
- New Personalized Cancer Vaccine Is Safe And Shows Promise, Early Clinical Trial Showson April 12, 2021 at 6:31 am
A new personalized cancer vaccine has raised no safety concerns and has shown potential benefit to patients with different cancers, including lung and blad ...
- Patient-derived organoids as a predictive biomarker for treatment response in cancer patientson April 11, 2021 at 5:00 pm
Effective predictive biomarkers are needed to enable personalized medicine and increase treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and treatment costs.
- Personalized cancer vaccine is safe, shows potential benefit against canceron April 11, 2021 at 9:44 am
A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung ...
The Latest Google Headlines on:
Personalized cancer therapies
The Latest Bing News on:
- Worldwide Electronic Skin Patches Industry to 2031 - Commercialized Mainly for Healthcare and Personalized Medicine Applicationson April 14, 2021 at 10:57 am
Flexible and stretchable skin patches are being commercialized mainly for healthcare and personalized medicine applications. Applications include: Key Topics Covered: 1 EXECUTIVE SUMMARY 1.1 The ...
- ImpriMed Raises $8M to Commercialize AI-Driven Personalized Drug Response Prediction Service in ...on April 13, 2021 at 5:02 am
ImpriMed utilizes artificial intelligence (AI) to predict which anti-cancer drugs are most likely to be effective for a particular dog’s lymphoma or leukemia using live data generated from ...
- Personalized medicine: How NorthShore University HealthSystem has integrated genomics into primary careon April 12, 2021 at 10:31 pm
" As we look at personalized medicine, it’s about ensuring patients – and their families – have the most comprehensive care plans, incorporating both traditional elements of care with genomics and ...
- MCI Onehealth Announces Partnership with Innovation and Personalized Care Leader, ReGen Scientificon April 12, 2021 at 3:53 pm
ReGen Co-Founder Dr. Robert Francis to join MCI Onehealth Board of AdvisorsMCI Onehealth to offer commercial support in long-term partnership with ReGen, a leader in innovation and personalized, ...
- New Miami-based initiative AccurePCI to catalyze personalized medicine innovation in Miami-Dadeon April 12, 2021 at 1:31 pm
AccurePCI, a project partnership of Miami foundation Global CoCreation Lab and Silicon Valley-based Cipherome announced today, will address ...
- Powering Precision Health Founder Leads Conversation at the Precision Medicine Leaders Summit on Disrupting Precision Health with Next-Generation Proton April 12, 2021 at 12:42 pm
Founded by Kevin Hrusovsky, a widely acclaimed thought leader and visionary in life sciences and personalized medicine, Powering Precision Health is a movement that represents the intersection of new ...
- Evolving World of Biomarker Testing and Therapeutic Strategies: Realizing the Promise of Personalized Medicineon April 12, 2021 at 11:10 am
Evolving World of Biomarker Testing & Therapeutic Strategies: Realizing the Promise of Personalized Medicine. Presented at: COA Community Oncology Conference 2021. Presented April 8, 2021. Accessed ...
- Personalized Medicine Market Outlook: World Approaching Demand & Growth Prospect 2021-2026 | Quest Diagnostic ,Laboratory Corporation ,Bectonon April 12, 2021 at 6:38 am
Latest released the research study on Global Personalized Medicine Market, offers a detailed overview of the factors influencing the global business scope. Personalized Medicine Market research report ...
- PARP Inhibitors Could Help Craft Better Personalized Medicine in Prostate Canceron April 7, 2021 at 9:53 am
Tanya Dorff, MD, discusses how the FDA approvals of olaparib and rucaparib have paved the way for additional research with PARP inhibitors in metastatic castration-resistant prostate cancer.
- Personalized Medicine Market | 2021 Global Industry Analysis By Covid-19 Impact On Healthcare Sector, Business With Forecast To 2026on April 5, 2021 at 3:27 am
Apr 05, 2021 (The Expresswire) -- The rising number of clinical trials on neurology and other disciplines of healthcare is propelling the growth of the personalized medicine market, says Fortune ...